Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue

Clinical Cancer Research

Volumn 7, Issue 12, 2001, Pages 4136-4142

  Sasaki, N ^a   Morisaki, T ^a   Hashizume, K ^a   Yao, T ^a   Tsuneyoshi, M ^a   Noshiro, H ^a   Nakamura, K ^a   Yamanaka, T ^a   Uchiyama, A ^a   Tanaka, M ^a   Katano, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; RNA; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; UROKINASE; PROTEIN SUBUNIT; TUMOR MARKER;

ADULT; ARTICLE; CANCER INVASION; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR VOLUME; ACTIVE TRANSPORT; CANCER STAGING; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PATHOLOGY; STOMACH TUMOR; SURVIVAL RATE; TIME;

ACTIVE TRANSPORT, CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NF-KAPPA B; PROTEIN SUBUNITS; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035542950     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Activators and target genes of Rel/NF-κB transcription factors
2. The NF-κB and IκB proteins: New discoveries and insights
3. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
4. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB
5. The Toll-receptor family and control of innate immunity
6. Structure, regulation and function of NF-κB
7. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells
8. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
9. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates
10. Role of NF-κB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2
11. The NF-κB transcription factor and cancer: High expression of NF-κB- and IκB-related proteins in tumor cell lines
12. Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma
13. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
14. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression
15. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells
16. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IκBα overexpression
17. The nuclear factor-κB Re1A transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
18. Aberrant nuclear factor-κB/Re1 expression and the pathogenesis of breast cancer
19. Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma
20. Inhibition of NF-κB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1
21. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
22. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus
23. Rapid polymerization of LR-White for immunocytochemistry
24. Constitutive nuclear translocation of NF-κB in B cells in the absence of IκB degradation
25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
26. Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration
27. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
28. Defining the invasive phenotype of proximal gastric cancer cells
29. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
30. NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin lα
31. Tumor associated proteolysis and prognosis: New functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system
32. Cysteine and serine proteases in gastric cancer
33. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
34. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity
35. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line
36. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor
37. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors
38. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
39. Re1/NF-κB transcription factors and the control of apoptosis